Director, Medical Affairs Operations
Summit Therapeutics · Princeton, NJ
$190k–$237k/yr
Summit TherapeuticsPrinceton, NJOn-sitePosted 3 days ago
$203k–$253k/yr listed by the employer
On Summit Therapeutics’ own careers site (Greenhouse).
Trust score ready Nov 25
Summarised from the posting by AI and can be wrong. The full description is the source.
Sign in and add your resume to see which of this job's requirements it shows.
Sign in to check your matchSaved to your account, encrypted. The AI that reads it doesn't keep it or train on it.
From Summit Therapeutics’ careers site
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
-
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
-
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
-
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
-
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Location: Princeton, NJ Onsite
Overview of Role:
The Director, Strategic Analytics and Market Research will lead integrated market research and forward-looking strategic analytics across Summit’s portfolio of indications. This senior individual contributor will combine primary and secondary research with real-world data to size opportunities, anticipate market evolution, and guide portfolio, launch, and long-range decisions for ivonescimab.
This role offers broad ownership across priority tumor areas and direct influence on portfolio, launch, and long-range decisions. The successful candidate will help shape Summit’s integrated insights and strategic analytics capability as ivonescimab advances toward commercialization, with regular exposure to senior cross-functional leaders. This is a senior individual-contributor role with broad cross-functional influence and direct exposure to portfolio, launch, and long-range decisions.
Role and Responsibilities:
Required Experience, Education and Skills:
This is the pay for this position
Pay Transparency
$203,000—$253,000 USD
Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Something wrong with this job? Report it
Summit Therapeutics · Princeton, NJ
$190k–$237k/yr
StrongChecked open todayPosted 1 month ago
Summit Therapeutics · Princeton, NJ
$180k–$200k/yrHybrid
StrongChecked open todayPosted 1 month ago
Summit Therapeutics · Palo Alto, CA +1 place
$217k–$271k/yr
StrongOpen 3 monthsChecked open todayPosted 3 months ago
Summit Therapeutics · and Palo Alto, CA +2 places
$174k–$204k/yrOn-site
StrongChecked open todayPosted 1 month ago
Summit Therapeutics · Princeton, NJ
$139k–$163k/yr
StrongChecked open todayPosted 1 month ago
Summit Therapeutics · Princeton, NJ
$400k–$480k/yr
StrongOpen 2 monthsChecked open todayPosted 2 months ago